XSHG
600624
Market cap366mUSD
Jul 10, Last price
3.71CNY
1D
1.37%
1Q
-17.92%
Jan 2017
-56.86%
Name
SHANGHAI FUDAN FORWARD S&T CO LTD
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shanghai Fudan Forward S&T Co., Ltd maintains a diverse business portfolio encompassing software development, biopharmaceuticals, and property ventures. Its software division specializes in creating and exporting programs, notably to the Japanese market. Within its biopharmaceutical operations, the firm conducts comprehensive research, development, manufacturing, and distribution of a range of products, including chemical drugs, traditional Chinese medicines, freeze-dried powder injections, and various solid dosage forms. The company's real estate arm focuses on the conceptualization and establishment of high-tech industrial parks. Beyond these, the enterprise is involved in the design, production, and sale of uninterruptible power supplies (UPS) and VRLA batteries, and also serves as an official agent for an automotive audio brand. Complementing these activities, it provides investment and advisory services, alongside venture capital funding. Founded in 1984, Shanghai Fudan Forward S&T Co., Ltd is headquartered in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||